Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001644956-25-000008
Filing Date
2025-02-12
Accepted
2025-02-12 16:35:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4975
  Complete submission text file 0001644956-25-000008.txt   6673
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Subject) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90866 | Film No.: 25615398
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606
Business Address 150 NORTH RIVERSIDE PLAZA CHICAGO IL 60606 312-236-1600
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by) CIK: 0001644956 (see all company filings)

EIN.: 472614791 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A